5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane

C206H305AlB3Br2ClN36O18Si5 — CID 160701589

About 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane

5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane (PubChem CID 160701589) has the molecular formula C206H305AlB3Br2ClN36O18Si5 and a molecular weight of 3969.05 g/mol. Its IUPAC name is 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane.

Molecular Properties

• Compound Name: 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane
• PubChem CID: 160701589
• Molecular Formula: C206H305AlB3Br2ClN36O18Si5
• Molecular Weight: 3969.05 g/mol
• Exact Mass: 3964.11
• IUPAC Name: 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane
• SMILES: CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3c(c2)nc(C(=O)NCCCN2CCCCC2)n3COCC[Si](C)(C)C)OC1(C)C.CCOC(=O)c1nc2cc(Br)ccc2n1COCC[Si](C)(C)C.C[Al](C)C.C[Si](C)(C)CCOCn1c(C(=O)NCCCN2CCCCC2)nc2cc(-c3cc(Cl)c4cnccc4n3)ccc21.C[Si](C)(C)CCOCn1c(C(=O)NCCCN2CCCCC2)nc2cc(-c3cc(Nc4ccc(CN5CCCC5)cc4)c4cnccc4n3)ccc21.C[Si](C)(C)CCOCn1c(C(=O)NCCCN2CCCCC2)nc2cc(Br)ccc21.NCCCN1CCCCC1.Nc1ccc(CN2CCCC2)cc1.O=C(NCCCN1CCCCC1)c1nc2ccc(-c3cc(Nc4ccc(CN5CCCC5)cc4)c4cnccc4n3)cc2[nH]1
• InChI: InChI=1S/C41H54N8O2Si.C35H40N8O.C30H39ClN6O2Si.C28H47BN4O4Si.C22H35BrN4O2Si.C16H23BrN2O3Si.C12H24B2O4.C11H16N2.C8H18N2.3CH3.Al/c1-52(2,3)25-24-51-30-49-39-15-12-32(26-38(39)46-40(49)41(50)43-17-9-23-47-19-5-4-6-20-47)36-27-37(34-28-42-18-16-35(34)45-36)44-33-13-10-31(11-14-33)29-48-21-7-8-22-48;44-35(37-14-6-20-42-16-2-1-3-17-42)34-40-30-12-9-26(21-33(30)41-34)31-22-32(28-23-36-15-13-29(28)39-31)38-27-10-7-25(8-11-27)24-43-18-4-5-19-43;1-40(2,3)17-16-39-21-37-28-9-8-22(26-19-24(31)23-20-32-12-10-25(23)34-26)18-27(28)35-29(37)30(38)33-11-7-15-36-13-5-4-6-14-36;1-27(2)28(3,4)37-29(36-27)22-12-13-24-23(20-22)31-25(33(24)21-35-18-19-38(5,6)7)26(34)30-14-11-17-32-15-9-8-10-16-32;1-30(2,3)15-14-29-17-27-20-9-8-18(23)16-19(20)25-21(27)22(28)24-10-7-13-26-11-5-4-6-12-26;1-5-22-16(20)15-18-13-10-12(17)6-7-14(13)19(15)11-21-8-9-23(2,3)4;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;12-11-5-3-10(4-6-11)9-13-7-1-2-8-13;9-5-4-8-10-6-2-1-3-7-10;;;;/h10-16,18,26-28H,4-9,17,19-25,29-30H2,1-3H3,(H,43,50)(H,44,45);7-13,15,21-23H,1-6,14,16-20,24H2,(H,37,44)(H,38,39)(H,40,41);8-10,12,18-20H,4-7,11,13-17,21H2,1-3H3,(H,33,38);12-13,20H,8-11,14-19,21H2,1-7H3,(H,30,34);8-9,16H,4-7,10-15,17H2,1-3H3,(H,24,28);6-7,10H,5,8-9,11H2,1-4H3;1-8H3;3-6H,1-2,7-9,12H2;1-9H2;3*1H3
• InChIKey: ARSJADVLINLBDD-UHFFFAOYSA-N
• XLogP: 39.80
• TPSA: 573.71 Ų
• H-Bond Donors: 10
• H-Bond Acceptors: 48
• Rotatable Bonds: 70
• Heavy Atoms: 272
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3969.05
LogP ≤ 5	39.80
H-Bond Donors ≤ 5	10
H-Bond Acceptors ≤ 10	48

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'anil_no_alk(40)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane?

The IUPAC name of 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane (CID 160701589) is 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane.

What is the SMILES notation for 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane?

The canonical SMILES for 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane is CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3c(c2)nc(C(=O)NCCCN2CCCCC2)n3COCC[Si](C)(C)C)OC1(C)C.CCOC(=O)c1nc2cc(Br)ccc2n1COCC[Si](C)(C)C.C[Al](C)C.C[Si](C)(C)CCOCn1c(C(=O)NCCCN2CCCCC2)nc2cc(-c3cc(Cl)c4cnccc4n3)ccc21.C[Si](C)(C)CCOCn1c(C(=O)NCCCN2CCCCC2)nc2cc(-c3cc(Nc4ccc(CN5CCCC5)cc4)c4cnccc4n3)ccc21.C[Si](C)(C)CCOCn1c(C(=O)NCCCN2CCCCC2)nc2cc(Br)ccc21.NCCCN1CCCCC1.Nc1ccc(CN2CCCC2)cc1.O=C(NCCCN1CCCCC1)c1nc2ccc(-c3cc(Nc4ccc(CN5CCCC5)cc4)c4cnccc4n3)cc2[nH]1.

What is the InChIKey of 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane?

The InChIKey is ARSJADVLINLBDD-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H54N8O2Si.C35H40N8O.C30H39ClN6O2Si.C28H47BN4O4Si.C22H35BrN4O2Si.C16H23BrN2O3Si.C12H24B2O4.C11H16N2.C8H18N2.3CH3.Al/c1-52(2,3)25-24-51-30-49-39-15-12-32(26-38(39)46-40(49)41(50)43-17-9-23-47-19-5-4-6-20-47)36-27-37(34-28-42-18-16-35(34)45-36)44-33-13-10-31(11-14-33)29-48-21-7-8-22-48;44-35(37-14-6-20-42-16-2-1-3-17-42)34-40-30-12-9-26(21-33(30)41-34)31-22-32(28-23-36-15-13-29(28)39-31)38-27-10-7-25(8-11-27)24-43-18-4-5-19-43;1-40(2,3)17-16-39-21-37-28-9-8-22(26-19-24(31)23-20-32-12-10-25(23)34-26)18-27(28)35-29(37)30(38)33-11-7-15-36-13-5-4-6-14-36;1-27(2)28(3,4)37-29(36-27)22-12-13-24-23(20-22)31-25(33(24)21-35-18-19-38(5,6)7)26(34)30-14-11-17-32-15-9-8-10-16-32;1-30(2,3)15-14-29-17-27-20-9-8-18(23)16-19(20)25-21(27)22(28)24-10-7-13-26-11-5-4-6-12-26;1-5-22-16(20)15-18-13-10-12(17)6-7-14(13)19(15)11-21-8-9-23(2,3)4;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;12-11-5-3-10(4-6-11)9-13-7-1-2-8-13;9-5-4-8-10-6-2-1-3-7-10;;;;/h10-16,18,26-28H,4-9,17,19-25,29-30H2,1-3H3,(H,43,50)(H,44,45);7-13,15,21-23H,1-6,14,16-20,24H2,(H,37,44)(H,38,39)(H,40,41);8-10,12,18-20H,4-7,11,13-17,21H2,1-3H3,(H,33,38);12-13,20H,8-11,14-19,21H2,1-7H3,(H,30,34);8-9,16H,4-7,10-15,17H2,1-3H3,(H,24,28);6-7,10H,5,8-9,11H2,1-4H3;1-8H3;3-6H,1-2,7-9,12H2;1-9H2;3*1H3;.

What are the key properties of 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane?

5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane has a molecular weight of 3969.05 g/mol, XLogP of 39.80, 70 rotatable bonds, 10 hydrogen bond donors, and 48 hydrogen bond acceptors.

Where does this data come from?

All data for 5-bromo-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;5-(4-chloro-1,6-naphthyridin-2-yl)-N-(3-piperidin-1-ylpropyl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;ethyl 5-bromo-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxylate;3-piperidin-1-ylpropan-1-amine;N-(3-piperidin-1-ylpropyl)-6-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1H-benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-[4-[4-(pyrrolidin-1-ylmethyl)anilino]-1,6-naphthyridin-2-yl]-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;N-(3-piperidin-1-ylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)benzimidazole-2-carboxamide;4-(pyrrolidin-1-ylmethyl)aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethylalumane is sourced from PubChem (CID 160701589), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).